Lee H. Pai

2.1k total citations
37 papers, 1.8k citations indexed

About

Lee H. Pai is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Biotechnology. According to data from OpenAlex, Lee H. Pai has authored 37 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Immunology, 17 papers in Radiology, Nuclear Medicine and Imaging and 16 papers in Biotechnology. Recurrent topics in Lee H. Pai's work include Toxin Mechanisms and Immunotoxins (25 papers), Monoclonal and Polyclonal Antibodies Research (15 papers) and Transgenic Plants and Applications (14 papers). Lee H. Pai is often cited by papers focused on Toxin Mechanisms and Immunotoxins (25 papers), Monoclonal and Polyclonal Antibodies Research (15 papers) and Transgenic Plants and Applications (14 papers). Lee H. Pai collaborates with scholars based in United States, United Kingdom and Austria. Lee H. Pai's co-authors include Ira Pastan, Mark C. Willingham, Ira Pastan, Ulrich Brinkmann, Kai Chang, D J FitzGerald, Janendra K. Batra, David J. FitzGerald, Robert E. Wittes and Ann Setser and has published in prestigious journals such as Proceedings of the National Academy of Sciences, JAMA and Nature Medicine.

In The Last Decade

Lee H. Pai

37 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lee H. Pai United States 24 766 699 599 469 392 37 1.8k
Luis E. Fernández Cuba 31 1.3k 1.7× 577 0.8× 1.1k 1.9× 132 0.3× 544 1.4× 70 2.2k
Isolda Casanova Spain 27 418 0.5× 199 0.3× 1.0k 1.7× 175 0.4× 709 1.8× 67 1.9k
Philip M. Wallace United States 24 1.2k 1.6× 567 0.8× 787 1.3× 316 0.7× 532 1.4× 36 2.3k
Mingqian Feng China 18 371 0.5× 295 0.4× 598 1.0× 125 0.3× 360 0.9× 49 1.3k
Alberto Gallardo Spain 28 394 0.5× 225 0.3× 1.1k 1.9× 98 0.2× 822 2.1× 70 2.4k
Francine M. Foss United States 32 1.7k 2.3× 187 0.3× 775 1.3× 182 0.4× 1.0k 2.7× 128 3.7k
Magali Schreyer Switzerland 24 702 0.9× 1.2k 1.7× 747 1.2× 63 0.1× 531 1.4× 40 2.0k
Vic Raso United States 13 332 0.4× 296 0.4× 419 0.7× 159 0.3× 350 0.9× 26 1.2k
Eugen Dhimolea United States 13 394 0.5× 614 0.9× 909 1.5× 74 0.2× 463 1.2× 28 1.7k
Bruce Freimark United States 17 785 1.0× 183 0.3× 997 1.7× 71 0.2× 458 1.2× 43 2.1k

Countries citing papers authored by Lee H. Pai

Since Specialization
Citations

This map shows the geographic impact of Lee H. Pai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lee H. Pai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lee H. Pai more than expected).

Fields of papers citing papers by Lee H. Pai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lee H. Pai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lee H. Pai. The network helps show where Lee H. Pai may publish in the future.

Co-authorship network of co-authors of Lee H. Pai

This figure shows the co-authorship network connecting the top 25 collaborators of Lee H. Pai. A scholar is included among the top collaborators of Lee H. Pai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lee H. Pai. Lee H. Pai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yerushalmi, Noga, Ulrich Brinkmann, Elisabeth Brinkmann, Lee H. Pai, & Ira Pastan. (2000). Attenuating the growth of tumors by intratumoral administration of DNA encoding Pseudomonas exotoxin via cationic liposomes. Cancer Gene Therapy. 7(1). 91–96. 18 indexed citations
2.
Zujewski, J., Lee H. Pai, Lalage M. Wakefield, et al.. (1999). Tamoxifen and fenretinide in women with metastatic breast cancer. Breast Cancer Research and Treatment. 57(3). 277–283. 30 indexed citations
3.
Čulig, Zoran, A Hittmair, Alfred Hobisch, et al.. (1998). Expression of Lewis carbohydrate antigens in metastatic lesions from human prostatic carcinoma. The Prostate. 36(3). 162–167. 11 indexed citations
4.
Pai, Lee H. & Ira Pastan. (1998). Clinical Trials with Pseudomonas Exotoxin Immunotoxins. Current topics in microbiology and immunology. 234. 83–96. 15 indexed citations
5.
Pai, Lee H., et al.. (1997). Identification of epitopes on a mutant form of Pseudomonas exotoxin using serum from humans treated with Pseudomonas exotoxin containing immunotoxins. European Journal of Immunology. 27(6). 1459–1468. 19 indexed citations
6.
Pai, Lee H., Robert E. Wittes, Ann Setser, Mark C. Willingham, & Ira Pastan. (1996). Treatment of advanced solid tumors with immunotoxin LMB–1: An antibody linked to Pseudomonas exotoxin. Nature Medicine. 2(3). 350–353. 159 indexed citations
7.
Pastan, Ira, Lee H. Pai, Ulrich Brinkmann, & David FitzGerald. (1996). Recombinant immunotoxins. Breast Cancer Research and Treatment. 38(1). 3–9. 14 indexed citations
8.
Pastan, Ira, Gary E. Archer, Roger E. McLendon, et al.. (1995). Intrathecal administration of single-chain immunotoxin, LMB-7 [B3(Fv)-PE38], produces cures of carcinomatous meningitis in a rat model.. Proceedings of the National Academy of Sciences. 92(7). 2765–2769. 29 indexed citations
9.
10.
Pastan, Ira, et al.. (1995). Recombinant Toxins: New Therapeutic Agents for Cancer. Annals of the New York Academy of Sciences. 758(1). 345–354. 38 indexed citations
11.
Wakefield, Lalage M., John J. Letterio, David Danielpour, et al.. (1995). Transforming growth factor-beta1 circulates in normal human plasma and is unchanged in advanced metastatic breast cancer.. PubMed. 1(1). 129–36. 139 indexed citations
12.
Camera, Luigi, Seigo Kinuya, Kayhan Garmestani, et al.. (1994). Comparative biodistribution of indium- and yttrium-labeled B3 monoclonal antibody conjugated to either 2-(p-SCN-Bz)-6-methyl-DTPA (1 B4M-DTPA) or 2-(p-SCN-Bz)-1,4,7,10-tetraazacyclododecane tetraacetic acid (2B-DOTA). European Journal of Nuclear Medicine and Molecular Imaging. 21(7). 640–646. 38 indexed citations
13.
Camera, Luigi, Seigo Kinuya, Kayhan Garmestani, et al.. (1993). Evaluation of a new DTPA-derivative chelator: Comparative biodistribution and imaging studies of 111In-labeled B3 monoclonal antibody in athymic mice bearing human epidermoid carcinoma xenografts. Nuclear Medicine and Biology. 20(8). 955–962. 18 indexed citations
14.
Pai, Lee H. & Ira Pastan. (1993). The use of immunotoxins for cancer therapy. European Journal of Cancer. 29(11). 1606–1609. 9 indexed citations
15.
Kunwar, Sandeep, Lee H. Pai, & Ira Pastan. (1993). Cytotoxicity and antitumor effects of growth factor-toxin fusion proteins on human glioblastoma multiforme cells. Journal of neurosurgery. 79(4). 569–576. 40 indexed citations
16.
Pai, Lee H.. (1993). Immunotoxin therapy for cancer. JAMA. 269(1). 78–81. 11 indexed citations
17.
Camera, Luigi, Seigo Kinuya, Lee H. Pai, et al.. (1993). Preclinical evaluation of 111In-labeled B3 monoclonal antibody: biodistribution and imaging studies in nude mice bearing human epidermoid carcinoma xenografts.. PubMed. 53(12). 2834–9. 25 indexed citations
18.
Pai, Lee H., Sandra M. Swain, David Venzon, et al.. (1992). Therapy off patients with metastatic breast cancer with 5-fluorouracil, leucovorin and carboplatin. Anti-Cancer Drugs. 3(5). 463–470. 5 indexed citations
19.
Chang, Kai, Lee H. Pai, Harvey I. Pass, et al.. (1992). Monoclonal Antibody K1 Reacts With Epithelial Mesothelioma but not With Lung Adenocarcinoma. The American Journal of Surgical Pathology. 16(3). 259–268. 137 indexed citations
20.
Pai, Lee H. & Ananda S. Prasad. (1988). Cellular zinc in patients with diabetes mellitus. Nutrition Research. 8(8). 889–897. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Luis E. Fernández Breakdown of academic impact, for papers by Isolda Casanova Breakdown of academic impact, for papers by Philip M. Wallace Breakdown of academic impact, for papers by Mingqian Feng Breakdown of academic impact, for papers by Alberto Gallardo Breakdown of academic impact, for papers by Francine M. Foss Breakdown of academic impact, for papers by Magali Schreyer Breakdown of academic impact, for papers by Vic Raso Breakdown of academic impact, for papers by Eugen Dhimolea Breakdown of academic impact, for papers by Bruce Freimark
Rankless by CCL
2026